Among them, TNBC with negative immunohistochemical results for estrogen receptor (ER), progesterone receptor (PR), and HER2 in the breast cancer tissue (3) is a highly heterogenous disease with an extremely poor prognosis. This evidence concerns the gene ERBB2 and breast carcinoma.